Get the updated Prostate Cancer Patient Guide 2021 Edition, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.


Progress Report: Towia Libermann, Ph.D; Alan Rigby, Ph.D

Co-Investigator: Towia Libermann, PhD–Associate Professor, Medicine, Director, Genomics and Proteomics, Beth Israel Deaconess Medical Center, Harvard Medical School, Director, Dana Farber Cancer Institute Cancer Proteomics Core, Harvard Medical School Co-Investigator: Alan Rigby, PhD–Assistant Professor, Medicine, Director, Program in Drug Discovery and Target Validation, Beth Israel Deaconess Medical Center, Harvard Medical. Read More


Progress Report: David Heber, MD, Ph.D

Investigator: David Heber, MD, PhD–Professor, Medicine and Public Health, Director, Center for Human Health, Chief, Division of Clinical Nutrition in the Department of Medicine, University of California, Los Angeles Development of an Ex Vivo Bioassay to Examine Modulation of PSA-Positive Macrophage Invasiveness and Inflammatory Activities in Prostate Cancer Patients with. Read More


Progress Report: Barbara Graves, Ph.D; Peter Hollenhorst, Ph.D

Co-Investigator: Barbara Graves, PhD –Professor and Chair, Oncological Sciences, Senior Director for Lab Research, Huntsman Cancer Institute, University of Utah Co-Investigator: Peter Hollenhorst, PhD –Assistant Professor, Biochemistry and Molecular Biology, School of Medicine, Indiana University ETS Protein Targets in Prostate Cancer—Understanding Gene Activity that Likely Causes Up to 60 Percent. Read More


Progress Report: Karen Knudsen, Ph.D; Adam Dicker, MD, Ph.D

Co-Investigator: Karen Knudsen, PhD–Associate Professor, Department of Cancer Biology and Urology at the Kimmel Cancer Center, Thomas Jefferson University Co-Investigator: Adam Dicker, MD, PhD–Professor, Chairman of Radiation Oncology, Director of Christine Baxter Research Laboratory for Experimental Cancer Therapies, Co-Director Radiation Research and Translational Biology Program at the Kimmel Cancer Center,. Read More


Progress Report: Shelton Earp, MD; Joseph Desimone, Ph.D

Co-Investigator: Shelton Earp, MD– Director and Lineberger Professor, Professor of Medicine and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill Co-Investigator: Joseph DeSimone, PhD–Chancellor’s Eminent Professor of Chemistry, University of North Carolina-Chapel Hill, William R. Kenan, Jr. Distinguished Professor of Chemical Engineering, North Carolina State University Application of. Read More


Progress Report: Cory Abate-Shen, Ph.D

Investigator: Cory Abate-Shen, PhD–Professor of Urology and Pathology, Director of Research, Department of Urology, Associate Director, Herbert Irving Comprehensive Cancer Center, Columbia University Identification of Oncogenic Pathways Conserved from Mouse to Man Dr. Abate-Shen’s research goals are to identify new molecules that drive prostate cancer progression. Her approach to this. Read More



PCF-Department of Defense Prostate Cancer Clinical Trials Consortium (PCCTC) As part of its aggressive plan to fund and accelerate research—and to speed the results to patients worldwide—PCF has invested more than $45 million in a consortium of 13 leading cancer centers, featuring some of the world’s most respected prostate cancer clinical. Read More


Progress Reports

As part of the award agreement, investigators are expected to make routine progress reports. Members of PCF’s Science Department regularly meet with the award winners to check in on their research. Please check back for new reports as they will be posted as processed. 2009 Creativity Award Reports Cory Abate-Shen, PhD Shelton Earp,. Read More


A New Generation of Researchers Pioneers Life Saving Solutions

PCF's Young Investigator Program gives recent MDs and PhDs the opportunity to conduct breakthrough research at a critical point in their careers as professional scientists. For these researchers, the first 7 or so years following the conferral of the terminal degree is a precarious and uncertain time. Academic positions are in. Read More


Not Your Father’s Prostate Cancer

What do recent medical advances mean for men and their families today, and how is this different from the experience of their fathers and grandfathers before them? And what does the future hold? Read More